P. Lichtenberg

发表

U. Nitzan, P. Lichtenberg, 2004, BMJ : British Medical Journal.

Physician perception regarding side-effect profile at the onset of antidepressant treatment: a survey of Israeli psychiatrists and primary care physicians

G. Walter, Y. Bloch, U. Nitzan, 2016, Annals of General Psychiatry.

From the closed ward to Soteria: a professional and personal journey

P. Lichtenberg, 2017 .

Interrelationship of Age, Depression, and Central Serotonergic Function: Evidence From Fenfluramine Challenge Studies

M. Gorfine, B. Lerer, P. Lichtenberg, 1996, International Psychogeriatrics.

Comparison of cost, dosage and clinical preference for risperidone and olanzapine

J. Rabinowitz, P. Lichtenberg, Z. Kaplan, 2000, Schizophrenia Research.

Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function

B. Lerer, P. Lichtenberg, M. Newman, 2005, Psychopharmacology.

Hypnotizability and Sensorimotor Gating: A Dopaminergic Mechanism of Hypnosis

R. Ebstein, P. Lichtenberg, R. Levin, 2011, The International journal of clinical and experimental hypnosis.

Hypnotherapeutic Olfactory Conditioning (HOC): Case Studies of Needle Phobia, Panic Disorder, and Combat-Induced PTSD

P. Lichtenberg, Eitan G. Abramowitz, 2009, The International journal of clinical and experimental hypnosis.

Does the Effect of Lithium on G-Proteins Have Behavioral Correlates?

R. Belmaker, J. Zohar, P. Lichtenberg, 1990 .

The Role of the Placebo in Clinical Practice

P. Lichtenberg, 2008, McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students.

Hypnotic Susceptibility: Multidimensional Relationships With Cloninger’s Tridimensional Personality Questionnaire, COMT Polymorphisms, Absorption, and Attentional Characteristics

R. Ebstein, H. Crawford, P. Lichtenberg, 2004, The International journal of clinical and experimental hypnosis.

Israeli Norms for the Stanford Hypnotic Susceptibility Scale, Form C

Y. Kalish, P. Lichtenberg, Eitan G. Abramowitz, 2009, The International journal of clinical and experimental hypnosis.

Measuring the effects of treatment with antipsychotics.

U. Nitzan, P. Lichtenberg, G. Mayer, 2015, JAMA psychiatry.

Consenting Not to Be Informed: A Survey on the Acceptability of Placebo Use in the Treatment of Depression

Y. Bloch, U. Nitzan, P. Lichtenberg, 2013, The Journal of nervous and mental disease.

therapy in patients with major depression Enhanced serotonergic responsivity following electroconvulsive

T. Cooper, B. Lerer, A. Calev, 2011 .

Bayesian approach to bipolar guidelines

P. Lichtenberg, Y. Bersudsky, R. Belmaker, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

A pilot double-blind comparison of d-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia

D. Javitt, K. Hashimoto, P. Lichtenberg, 2013, Schizophrenia Research.

Very high-dose clozapine and electroconvulsive therapy combination treatment in a patient with schizophrenia.

P. Lichtenberg, H. Drexler, S. Keller, 2009, The journal of ECT.

Implications of Clinical Spectrum for Mechanisms of Action: ECT and Antidepressants Reconsidered.

B. Lerer, P. Lichtenberg, 1989, Convulsive therapy.

AVPR1a and SLC6A4 Gene Polymorphisms Are Associated with Creative Dance Performance

Christian Dina, Pesach Lichtenberg, R. Ebstein, 2005, PLoS genetics.

De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample

A. Heguy, D. Malaspina, Y. Friedlander, 2015, Schizophrenia Research.

Developing a Case Management Strategy in Israel

P. Lichtenberg, Z. Kaplan, D. Feldman, 2004, Administration and Policy in Mental Health and Mental Health Services Research.

The Residential Care Alternative for the Acutely Psychotic Patient

P. Lichtenberg, 2011, Psychiatric Quarterly.

A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression

I. Kirsch, W. Brown, P. Lichtenberg, 2012, PloS one.

Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial.

I. Kirsch, Y. Braw, Y. Bloch, 2020, Journal of affective disorders.

Suggestibility as a predictor of response to antidepressants: A preliminary prospective trial.

Y. Braw, U. Nitzan, P. Lichtenberg, 2015, Journal of affective disorders.

Older paternal age strongly increases the morbidity for schizophrenia in sisters of affected females

D. Malaspina, P. Lichtenberg, M. Perrin, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Defensive self-presentation style is associated with reduced prepulse inhibition

R. Ebstein, P. Lichtenberg, R. Levin, 2011, European Neuropsychopharmacology.

Reduced prepulse inhibition is associated with increased hypnotizability.

P. Lichtenberg, R. Levin, U. Heresco-Levy, 2008, The international journal of neuropsychopharmacology.

Hormone responses to fenfluramine and placebo challenge in endogenous depression

T. Cooper, B. Lerer, P. Lichtenberg, 1992, Psychiatry Research.

The psychometric properties of the Hebrew version of Cloninger's Tridimensional Personality Questionnaire

R. Ebstein, Y. Osher, J. Benjamin, 2001 .

Hypnotizability and Blink Rate: A Test of the Dopamine Hypothesis

P. Lichtenberg, R. Levin, U. Heresco-Levy, 2008, The International journal of clinical and experimental hypnosis.

Freud's Relevance to Hypnosis: A Reevaluation

P. Lichtenberg, R. Bachner-Melman, 2001, The American journal of clinical hypnosis.

The Soteria model: implementing an alternative to acute psychiatric hospitalization in Israel

P. Lichtenberg, D. Tzur Bitan, A. Friedlander, 2022, Psychosis.

Don't Call Me “Nudge”: The Ethical Obligation to Use Effective Interventions to Promote Public Health

Pesach Lichtenberg, P. Lichtenberg, Azgad Gold, 2012, The American journal of bioethics : AJOB.

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia

Daniel C. Javitt, Pesach Lichtenberg, D. Javitt, 2005, Biological Psychiatry.

Think Yourself Thin: Concern for Appropriateness Mediates the Link Between Hypnotizability and Disordered Eating

P. Lichtenberg, R. Levin, R. Bachner-Melman, 2016, The International journal of clinical and experimental hypnosis.

Effects of lithium in vitro on noradrenaline-induced cyclic AMP accumulation in rat cortical slices after reserpine-induced supersensitivity

R. Belmaker, P. Lichtenberg, M. Newman, 1985, Neuropharmacology.

Exploratory association study between catechol-O-methyltransferase (COMT) high/low enzyme activity polymorphism and hypnotizability.

R. Ebstein, P. Lichtenberg, I. Gritsenko, 2000, American journal of medical genetics.

No Link between Hypnotizability and the Self-Monitoring Scale

R. Ebstein, P. Lichtenberg, R. Bachner-Melman, 2002, The American journal of clinical hypnosis.

Hypnotizability Is Associated With a Protective but Not Acquisitive Self-Presentation Style

R. Ebstein, P. Lichtenberg, R. Levin, 2013, The International journal of clinical and experimental hypnosis.

The moral case for the clinical placebo

P. Lichtenberg, Azgad Gold, 2013, Journal of Medical Ethics.

Clinical Placebo Can Be Defined Positively: Implications for Informed Consent

P. Lichtenberg, Azgad Gold, 2015, The American journal of bioethics : AJOB.

Age, sex and first treatment of schizophrenia in a population cohort.

D. Malaspina, M. Weiser, P. Lichtenberg, 2011, Journal of psychiatric research.

A comparative study with depressed patients on the acceptability of placebo use.

Y. Bloch, U. Nitzan, P. Lichtenberg, 2016, General hospital psychiatry.

Standards and Guidelines for the Development of Diagnostic Nomenclatures and Alternatives in Mental Health Research and Practice

P. Lichtenberg, E. Flanagan, B. Robbins, 2019 .

A New Hypnotic Technique for Treating Combat-Related Posttraumatic Stress Disorder: A Prospective Open Study

P. Lichtenberg, Eitan G. Abramowitz, 2010, The International journal of clinical and experimental hypnosis.

Subtyping Major Depressive Disorder

R. Belmaker, P. Lichtenberg, Robert H. Belmaker, 2010, Psychotherapy and Psychosomatics.

Catatonic schizophrenia: a cohort prospective study.

D. Malaspina, M. Weiser, P. Lichtenberg, 2012, Schizophrenia bulletin.

Time-to-pregnancy and risk of schizophrenia

D. Malaspina, P. Lichtenberg, J. Gangwisch, 2010, Schizophrenia Research.

Psychotic exacerbation in a patient with seizure disorder treated with vagus nerve stimulation.

P. Lichtenberg, Shikma Keller, 2008, The Israel Medical Association journal : IMAJ.

An Interaction between the Catechol O-Methyltransferase and Serotonin Transporter Promoter Region Polymorphisms Contributes to Tridimensional Personality Questionnaire Persistence Scores in Normal Subjects

R. Ebstein, Y. Osher, R. Belmaker, 2000, Neuropsychobiology.

Israeli Norms for the Harvard Group Scale of Hypnotic Susceptibility, Form A

P. Lichtenberg, 2008, The International journal of clinical and experimental hypnosis.

Reduction in inpatient length of stay and changes in mental health care in Israel over four decades: a national case register study.

D. Levinson, P. Lichtenberg, Y. Lerner, 2003, Israel journal of psychiatry and related sciences.

De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample

A. Heguy, D. Malaspina, Y. Friedlander, 2015, Schizophrenia Research.

The moral case for the clinical placebo

P. Lichtenberg, Azgad Gold, 2013, Journal of Medical Ethics.

Politics and Psychopathology in an Arab-Israeli Patient

P. Lichtenberg, U. Heresco-Levy, A. Vass, 2003, Psychiatry.

Hypnotherapeutic Olfactory Conditioning (HOC): Case Studies of Needle Phobia, Panic Disorder, and Combat-Induced PTSD

P. Lichtenberg, Eitan G. Abramowitz, 2009, The International journal of clinical and experimental hypnosis.

Effect of fenfluramine on mood: A double-blind placebo-controlled trial

B. Lerer, A. Calev, P. Lichtenberg, 1992, Biological Psychiatry.